SEC Form 4 · accession 0001442002-16-000001
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Mikah Pharma, LLC
10% Owner
Nasrat A Hakim
Officer — President & CEO · Director · 10% Owner
Period of report
Oct 30, 2015
Accepted (ET)
Jan 8, 2016 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| commonF1,F2,F3 | Oct 30, 2015 | J | 113,954 | $0.00 | A | 113,954 | I | See Footnote |
| Common StockF4 | holding | — | — | — | 19,072,514 | D | ||
| Common Stock | holding | — | — | — | 2,700,000 | I | by IRA of Nasrat Hakim |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Milestone payment from company pursuant to a Strategic Alliance Agreement with Entity.
- F2Shares eventually transferred from Entity in which Mikah Pharma LLC has a beneficial interest to Mikah Pharma LLC.
- F3The securities are held by Mikah Pharma LLC. Nasrat Hakim is the sole beneficial owner of Mikah Pharma LLC.
- F4The securities are held by Nasrat Hakim .